Jonathan Strosberg

21.1k total citations · 5 hit papers
291 papers, 9.9k citations indexed

About

Jonathan Strosberg is a scholar working on Oncology, Epidemiology and Neurology. According to data from OpenAlex, Jonathan Strosberg has authored 291 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 243 papers in Oncology, 243 papers in Epidemiology and 176 papers in Neurology. Recurrent topics in Jonathan Strosberg's work include Neuroendocrine Tumor Research Advances (242 papers), Lung Cancer Research Studies (208 papers) and Neuroblastoma Research and Treatments (176 papers). Jonathan Strosberg is often cited by papers focused on Neuroendocrine Tumor Research Advances (242 papers), Lung Cancer Research Studies (208 papers) and Neuroblastoma Research and Treatments (176 papers). Jonathan Strosberg collaborates with scholars based in United States, Italy and Germany. Jonathan Strosberg's co-authors include Larry K. Kvols, Mauro Cives, Domenico Coppola, Matthew H. Kulke, David S. Klimstra, James C. Yao, Junsung Choi, Jill Weber, Taymeyah Al‐Toubah and Aejaz Nasir and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Jonathan Strosberg

278 papers receiving 9.7k citations

Hit Papers

First‐line chemotherapy with capecitabine and temozolomid... 2010 2026 2015 2020 2010 2013 2018 2018 2022 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. First‐line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas
    2010 519 citations Jonathan Strosberg, Domenico Coppola et al. profile →
  2. Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors
    2013 426 citations Pamela L. Kunz, Diane Reidy‐Lagunes et al. Pancreas profile →
  3. Gastroenteropancreatic Neuroendocrine Tumors
    2018 392 citations Mauro Cives, Jonathan Strosberg profile →
  4. Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial
    2018 272 citations Jonathan Strosberg, Edward M. Wolin et al. Journal of Clinical Oncology profile →
  5. Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)
    2022 125 citations Pamela L. Kunz, Noah Graham et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Strosberg United States 51 8.1k 8.1k 5.8k 770 586 291 9.9k
Marianne Pavel Germany 32 7.4k 0.9× 7.9k 1.0× 5.7k 1.0× 830 1.1× 494 0.8× 130 9.1k
Jaume Capdevila Spain 32 6.6k 0.8× 6.6k 0.8× 4.6k 0.8× 806 1.0× 629 1.1× 128 8.0k
Edward M. Wolin United States 34 5.7k 0.7× 6.0k 0.7× 4.4k 0.8× 796 1.0× 395 0.7× 135 7.3k
Paola Tomassetti Italy 37 4.9k 0.6× 5.2k 0.6× 3.5k 0.6× 595 0.8× 900 1.5× 117 6.6k
Catherine Lombard‐Bohas France 39 5.3k 0.7× 5.1k 0.6× 3.6k 0.6× 609 0.8× 666 1.1× 168 6.7k
Alexandria T. Phan United States 41 7.6k 0.9× 7.7k 1.0× 5.4k 0.9× 863 1.1× 1.9k 3.2× 139 10.8k
Nicola Fazio Italy 45 4.8k 0.6× 4.0k 0.5× 2.7k 0.5× 498 0.6× 944 1.6× 270 6.5k
Halfdan Sørbye Norway 42 6.5k 0.8× 3.4k 0.4× 2.1k 0.4× 498 0.6× 1.5k 2.6× 160 8.1k
Diane Reidy‐Lagunes United States 38 4.3k 0.5× 3.0k 0.4× 2.1k 0.4× 535 0.7× 1.1k 1.9× 173 5.5k
Ivan Borbath Belgium 31 4.7k 0.6× 3.3k 0.4× 2.0k 0.3× 635 0.8× 1.5k 2.5× 155 6.3k

Countries citing papers authored by Jonathan Strosberg

Since Specialization
Citations

This map shows the geographic impact of Jonathan Strosberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Strosberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Strosberg more than expected).

Fields of papers citing papers by Jonathan Strosberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Strosberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Strosberg. The network helps show where Jonathan Strosberg may publish in the future.

Co-authorship network of co-authors of Jonathan Strosberg

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Strosberg. A scholar is included among the top collaborators of Jonathan Strosberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Strosberg. Jonathan Strosberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tacelli, Matteo, Manuel Gentiluomo, Justo P. Castaño, et al.. (2025). Pancreatic neuroendocrine neoplasms (pNENs): Genetic and environmental biomarkers for risk of occurrence and prognosis. Seminars in Cancer Biology. 112. 112–125. 3 indexed citations
2.
Sørbye, Halfdan, Grace Kong, Simona Grozinsky‐Glasberg, & Jonathan Strosberg. (2024). PRRT in high‐grade digestive neuroendocrine neoplasms ( NET G3 and NEC ). Journal of Neuroendocrinology. 37(3). e13443–e13443. 5 indexed citations
3.
4.
Barros, Milton, Jonathan Strosberg, Taymeyah Al‐Toubah, et al.. (2023). HORMONET: a phase II trial of tamoxifen for estrogen/progesterone receptor-positive neuroendocrine tumors. Therapeutic Advances in Medical Oncology. 15. 2630777–2630777. 4 indexed citations
5.
Sukrithan, Vineeth, Briant Fruth, Rui Qin, et al.. (2023). A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors. Endocrine Related Cancer. 30(11). 4 indexed citations
6.
Hope, Thomas A., Samuel A. Mehr, Michael J. Morris, et al.. (2023). ACTION-1: A Randomized Phase Ib/3 trial of RYZ101 Compared with SoC in SSTR2+ Well-Differentiated GEP-NET with Progression Following Lu-177 SSA. Endocrine Abstracts. 1 indexed citations
7.
Kunz, Pamela L., Noah Graham, Paul J. Catalano, et al.. (2022). Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211). Journal of Clinical Oncology. 41(7). 1359–1369. 125 indexed citations breakdown →
8.
Strosberg, Jonathan, et al.. (2022). Immune Checkpoint Inhibitors for Gastrointestinal Malignancies: An Update. Cancers. 14(17). 4201–4201. 2 indexed citations
9.
Mandriani, Barbara, Eleonora Pellè, Jonathan Strosberg, et al.. (2021). Adoptive T-cell immunotherapy in digestive tract malignancies: Current challenges and future perspectives. Cancer Treatment Reviews. 100. 102288–102288. 11 indexed citations
10.
Das, Satya, Taymeyah Al‐Toubah, & Jonathan Strosberg. (2021). Chemotherapy in Neuroendocrine Tumors. Cancers. 13(19). 4872–4872. 20 indexed citations
11.
Strosberg, Jonathan, Nobumasa Mizuno, Toshihiko Doi, et al.. (2020). Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Neuroendocrine Tumors: Results From the Phase II KEYNOTE-158 Study. Clinical Cancer Research. 26(9). 2124–2130. 146 indexed citations
12.
Al‐Toubah, Taymeyah, Jonathan Strosberg, Þorvarður R. Hálfdánarson, et al.. (2020). Somatostatin Analogs Improve Respiratory Symptoms in Patients With Diffuse Idiopathic Neuroendocrine Cell Hyperplasia. CHEST Journal. 158(1). 401–405. 19 indexed citations
13.
Strosberg, Jonathan, Þorvarður R. Hálfdánarson, Andrew M. Bellizzi, et al.. (2017). The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors. Pancreas. 46(6). 707–714. 262 indexed citations
14.
Caldeira, Christiano, et al.. (2016). Surgical Treatment of an Isolated Metastatic Myocardial Neuroendocrine Tumor. The Annals of Thoracic Surgery. 101(2). 747–749. 10 indexed citations
15.
Strosberg, Jonathan, Edward M. Wolin, Beth Chasen, et al.. (2016). NETTER-1 Phase III in Patients With Midgut Neuroendocrine Tumors Treated With 177Lu-DOTATATE: Efficacy and Safety Results.. Neuroendocrinology. 103(5 Suppl 7). 629–629. 19 indexed citations
16.
Strosberg, Jonathan, James C. Yao, Emilio Bajetta, et al.. (2015). Efficacy of Octreotide Long-Acting Repeatable (OCT) From the Phase III RADIANT-2 Study in Patients With Advanced Neuroendocrine Tumors (NET) : A Post-Hoc Analysis of the Placebo (PBO) Arm With Updated Survival Data. Pancreas. 44(2). 359–359. 1 indexed citations
17.
Hobday, Timothy J., Rui Qin, Diane Reidy‐Lagunes, et al.. (2014). Multicenter Phase II Trial of Temsirolimus and Bevacizumab in Pancreatic Neuroendocrine Tumors. Journal of Clinical Oncology. 33(14). 1551–1556. 96 indexed citations
18.
Kunz, Pamela L., Diane Reidy‐Lagunes, Lowell Anthony, et al.. (2013). Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors. Pancreas. 42(4). 557–577. 426 indexed citations breakdown →
19.
Dumont, Agathe, Lori Rink, Andrew K. Godwin, et al.. (2011). A nonrandom association of gastrointestinal stromal tumor (GIST) and desmoid tumor (deep fibromatosis): case series of 28 patients. Annals of Oncology. 23(5). 1335–1340. 33 indexed citations
20.
Strosberg, Jonathan, Asima Cheema, Jill Weber, et al.. (2011). Prognostic Validity of a Novel American Joint Committee on Cancer Staging Classification for Pancreatic Neuroendocrine Tumors. Journal of Clinical Oncology. 29(22). 3044–3049. 179 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marianne Pavel Breakdown of academic impact, for papers by Jaume Capdevila Breakdown of academic impact, for papers by Edward M. Wolin Breakdown of academic impact, for papers by Paola Tomassetti Breakdown of academic impact, for papers by Catherine Lombard‐Bohas Breakdown of academic impact, for papers by Alexandria T. Phan Breakdown of academic impact, for papers by Nicola Fazio Breakdown of academic impact, for papers by Halfdan Sørbye Breakdown of academic impact, for papers by Diane Reidy‐Lagunes Breakdown of academic impact, for papers by Ivan Borbath
Rankless by CCL
2026